Search research articles
Contact Us
Filters
Showing results (61-70 of 161) with videos related to
Page
of 17
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 30, 2010
Eliciting distributions to populate decision analytic models
Laura Bojke, Karl Claxton, Yolanda Bravo-Vergel, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
September 7, 2006
Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs
Christopher C Butler, Sharon Hillier, Zoë Roberts, et al.
Biochemical Pharmacology
|
March 18, 2014
Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation
Venkataraman Sriraman, Deborah Denis, Daniel de Matos, et al.
Steroids
|
April 7, 2006
Molecular properties and preclinical pharmacology of JNJ-1250132, a steroidal progesterone receptor modulator that inhibits binding of the receptor to DNA in vitro
George F Allan, Elizabeth Palmer, Amy Musto, et al.
Crisis
|
December 20, 2017
Hearing the Suicidal Patient's Emotional Pain
Christine Dunkley, Alan Borthwick, Ruth Bartlett, et al.
Pharmacoeconomics
|
June 13, 2016
The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence
James Lomas, Alexis Llewellyn, Marta Soares, et al.
Pharmacoeconomics
|
January 19, 2013
When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidance
Louise Longworth, Jihee Youn, Laura Bojke, et al.
Health Technology Assessment (Winchester, England)
|
December 19, 2022
EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation
Ana Duarte, Mark Corbett, Hollie Melton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2011
The CHD challenge: comparing four cost-effectiveness models
David Turner, James Raftery, Keith Cooper, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 30, 2016
Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?
Sophie Whyte, Simon Dixon, Rita Faria, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 161) with videos related to
Sort By:
Page
of 17
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 30, 2010
Eliciting distributions to populate decision analytic models
Laura Bojke, Karl Claxton, Yolanda Bravo-Vergel, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
September 7, 2006
Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs
Christopher C Butler, Sharon Hillier, Zoë Roberts, et al.
Biochemical Pharmacology
|
March 18, 2014
Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation
Venkataraman Sriraman, Deborah Denis, Daniel de Matos, et al.
Steroids
|
April 7, 2006
Molecular properties and preclinical pharmacology of JNJ-1250132, a steroidal progesterone receptor modulator that inhibits binding of the receptor to DNA in vitro
George F Allan, Elizabeth Palmer, Amy Musto, et al.
Crisis
|
December 20, 2017
Hearing the Suicidal Patient's Emotional Pain
Christine Dunkley, Alan Borthwick, Ruth Bartlett, et al.
Pharmacoeconomics
|
June 13, 2016
The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence
James Lomas, Alexis Llewellyn, Marta Soares, et al.
Pharmacoeconomics
|
January 19, 2013
When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidance
Louise Longworth, Jihee Youn, Laura Bojke, et al.
Health Technology Assessment (Winchester, England)
|
December 19, 2022
EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation
Ana Duarte, Mark Corbett, Hollie Melton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2011
The CHD challenge: comparing four cost-effectiveness models
David Turner, James Raftery, Keith Cooper, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 30, 2016
Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?
Sophie Whyte, Simon Dixon, Rita Faria, et al.
Page
of 17